AB
RCEL icon

Amalgamated Bank’s Avita Medical RCEL Stock Holding History

Amalgamated Bank’s Portfolio RCEL Stock Details RCEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-383
Closed -$1K – 2548
2025
Q4 		$1K Sell
383
-465
-55% -$1.85K ﹤0.01% 2954
2025
Q3 		$4K Hold
848
– – ﹤0.01% 2853
2025
Q2 		$4K Hold
848
– – ﹤0.01% 2865
2025
Q1 		$7K Hold
848
– – ﹤0.01% 2541
2024
Q4 		$11K Hold
848
– – ﹤0.01% 2397
2024
Q3 		$9K Hold
848
– – ﹤0.01% 2512
2024
Q2 		$7K Hold
848
– – ﹤0.01% 2639
2024
Q1 		$14K Sell
848
-2,711
-76% -$43.9K ﹤0.01% 2294
2023
Q4 		$49K Sell
3,559
-252
-7% -$2.89K ﹤0.01% 2260
2023
Q3 		$56K Hold
3,811
– – ﹤0.01% 2209
2023
Q2 		$65K Buy
+3,811
New +$55.9K ﹤0.01% 2217
2022
Q2 		– Sell
-3,967
Closed -$34K – 3169
2022
Q1 		$34K Buy
+3,967
New +$36.6K ﹤0.01% 2633

Other funds holding RCEL

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
DSCM
Divisadero Street Capital Management Miami, Florida $2.39B AUM 134.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Amalgamated Bank's RCEL Position: Q1 2026 in Review

Amalgamated Bank sold out of Avita Medical (RCEL) in Q1 2026, closing a stake of 383 shares — an estimated $1K sold.

Amalgamated Bank first reported a position in RCEL in Q1 2022 and held it in 12 quarters. The position peaked at $65K in Q2 2023. 79 funds tracked by Wall St. Rank hold RCEL as of Q1 2026.

  • Amalgamated Bank reported no remaining Avita Medical position as of Q1 2026 after selling out during the quarter.
  • Amalgamated Bank sold 383 Avita Medical shares in Q1 2026, an estimated $1K.
  • Amalgamated Bank first reported a position in Avita Medical in Q1 2022 and held it in 12 quarters.
  • Amalgamated Bank's Avita Medical position peaked at $65K in Q2 2023.
  • 79 funds tracked by Wall St. Rank held Avita Medical as of Q1 2026.

Based on Amalgamated Bank's 13F filing for Q1 2026, filed 8 May 2026.